期刊文献+

人胰腺癌5-Fu耐药细胞株的诱导建立及细胞学特性研究 被引量:3

Establishment and Characterization of 5-Fu-resistant Variant of Human Pancreatic Cancer Cell Line
下载PDF
导出
摘要 目的建立稳定传代的抵抗5-Fu的人胰腺癌细胞株MiaPaca2-5-Fu,并对细胞生物学特性进行研究。方法逐步增加培养基中5-Fu的浓度,建立对5-Fu耐药的人胰腺癌细胞株MiaPaca2-5-Fu;采用WST法计算出MiaPaca2和MiaPaca 2-5- Fu的半数抑制浓度(IC50)和耐药指敷(RI);检测MiaPaca2和MiaPaca2-5-Fu的生长曲线,计算2个细胞系的倍增时间并进行比较,用流式细胞仪技术检测其细胞周期。结果5-Fu对MiaPaca2和MiaPaca2-5-Fu的IC50分别为(4.29±0.15)μg/mL、(41.55±2.79)μg/mL,RI为9.68(P=0.0019)。根据生长曲线计算出MiaPaca2和MiaPaca2-5-Fu的倍增时间分别为(39.52±0.32)h、(43.27±0.33)h(P=0.0069),2细胞株的G0/G1期、S期、G2/M期均存在显著性差异(P<0.01)。结论成功建立了对5-Fu耐药的人胰腺癌细胞系MiaPaca2-5-Fu,耐药性能明显、稳定,适合于胰腺癌中5-Fu耐药机制的研究。 Objective To establish stable MiaPaca2 cell lines resistant to 5-Fu and describe the characteristics of this resistant variant. Methods Increase the concentration of 5-Fu, which was exposed to human pancreatic cancer cell line MiaPaca2 gradually to get the 5-Fu resistance cell line named MiaPaca 2-5-Fu. The IC50 and resistance index(RI) of MiaPaca2 and MiaPaca 2-5-Fu cell lines were measured by WST assay. Doubling time was calculated and compared based on the growth curve of these two cell lines, and cell cycles were assayed with flowcytometry method. Results The IC50 increased from (4.29 ± 0.15) μg/mL in MiaPaca2 to (41.55 ± 2.79) μg/mL in MiaPaca2-5-Fu after 72 h exposure and the RI was 9.68(P = 0. 0019). Doubling time of MiaPaca2 and MiaPaca2-5-Fu was (39.52±0.32) h and (43.27±0.33) h respectively (P=0.0069). The cell cycles of G0/G1 period, S period and G2/M period have a significant difference between these two cell lines(P〈0.01). Conclusion MiaPaca 2-5-Fu, the 5-Fu resistant phenotype, is a stable and suitable cell model for studying 5-Fu resistant in pancreatic cancer.
出处 《实用临床医药杂志》 CAS 2007年第5期52-54,共3页 Journal of Clinical Medicine in Practice
基金 江苏省自然科学基金助项目(BK2006531)
关键词 5-氟脲嘧啶 胰腺癌 耐药 5-Fu pancreatic cancer drug-resistant
  • 相关文献

参考文献9

  • 1Philadelphia P A, Lippincott Williams, Wilkins. Ontology [M]. Sixth Edition. DeVita VT, H S, Rosenberg SA, eds, 2001. 1126.
  • 2Berlin J D, Rothenberg M L. Chemotherapeutic advances in pancreatic cancer[J]. Curr Oncol Rep, 2003, (3): 219.
  • 3Stavrovskaya A A. Cellular mechanisms of multidrug resistance of tumor cell[J]. (Moscow), 2000, 65: 95.
  • 4Flens M J, Scheffer G L, Van Der Valk P, et al. Identification of novel drug resistance-associated by a panel of rat monoclonal antibodies[J]. Int Cancer, 1997, 73(2) : 249.
  • 5Snow K, Judd W. Characteristics of adriamydn-and amsacrine-resistant human leukaemic T cell line[J]. Br J Cancer, 1991, 63(1): 17.
  • 6Ishii K, Iwahana M, Mitsui I, et al. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP- mediated camptothecin derivative-reslstant variants derived from the human lung cancer line PC-6[J]. Anticancer drugs, 2000, 11(5): 356.
  • 7Bergrnan A M, Giaccone G, Van Moorsel G J. et ah Crossresistance in the 2', 2'-difluro-deoxycydine (gemicitabine) : resistant human ovarian cancer cell line AG6000 to standard and investigational drug[J]. Eur Cancer, 2000, 36: 1974.
  • 8Umezu Goto M, Kishi Y, Talva A, et al. Autotaxin has lysophosphlipase D activity leading to tumor cell growth and motility by lymphosphatidic acid production [J ]. J Cell Biol, 2002, 158(2): 227.
  • 9Hsieh J L, Wu C L, Lee C H, et al. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of P53 FUnction[J]. Clin Cancer Res, 2003, 9(1): 338.

同被引文献22

  • 1刘丽君,彭建新,洪华珠,叶雯,乔媛媛.线粒体在细胞凋亡中的变化与作用[J].细胞生物学杂志,2005,27(2):117-120. 被引量:44
  • 2葛勇胜,滕安宝,许戈良,李建生,陈炯,马金良,邵成颂,王成.微波固化治疗在手术不能切除胰腺癌中的应用[J].中国临床保健杂志,2005,8(2):114-115. 被引量:6
  • 3王榕生,穆庆霞,卢凯华,黄普文,刘平,束永前.高能聚焦超声热疗合并奥曲肽治疗晚期胰腺癌的随机临床对照研究[J].实用临床医药杂志,2005,9(5):28-31. 被引量:4
  • 4Shaw RJ, Glucose metabolism and cancer[ J]. Curr Opin Cell Biol, 2006,18(6) :598- 608.
  • 5Bartrons R, Cam J. Hypoxia, glucose metabolism and the Warburg's effect[ J]. J Bioenerg Biomembr,2007,39 ( 3 ) :223-229.
  • 6Kim JW, Dang CV. Cancer ' s molecular sweet tooth and the Warburg effect [ J ]. Cancer Res,2006,66 ( 18 ) :8927- 8930.
  • 7Kondoh H. Cellular life span and the Warburg effect[ J]. Exp Cell Res,2008,314(9) : 1923-1928.
  • 8Pelicano H, Martin DS, Xu RH, et al . Glycolysis inhibition for anticancer treatment [ J ]. Oncogene ,2006,25 (34) :4633- 4646.
  • 9Kroemer G. Mitochondria in cancer [ J ]. Oncogene, 2006, 25 (34) :4630- 4632.
  • 10Lapidot T, Sirard C, Vormoor J, et al. A cell initiating hunmn acute myeloid leukaemia after transplantation into SCID mice [J]. Nature, 1994, 367(6464) : 645.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部